APLT

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Applied Therapeutics Inc

NASDAQ | APLT

0.43

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 18, 2025)

$61.93M

Market Cap

-

P/E Ratio

-0.46

EPS

$10.62

52 Week High

$0.29

52 Week Low

HEALTHCARE

Sector

APLT Chart

Recent Chart
Price Action

APLT Technicals

Tags:

APLT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $455K
Total Revenue $455K
Cost Of Revenue $425K
Costof Goods And Services Sold $425K
Operating Income -$104M
Selling General And Administrative $56M
Research And Development $49M
Operating Expenses $105M
Investment Income Net -
Net Interest Income $3.5M
Interest Income $3.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $426K
Income Before Tax -$106M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$106M
Comprehensive Income Net Of Tax -
Ebit -$104M
Ebitda -$104M
Net Income -$106M

Revenue & Profitability

Earnings Performance

APLT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $87M
Total Current Assets $84M
Cash And Cash Equivalents At Carrying Value $79M
Cash And Short Term Investments $79M
Inventory -
Current Net Receivables -
Total Non Current Assets $3M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $4.2M
Other Non Current Assets -
Total Liabilities $30M
Total Current Liabilities $27M
Current Accounts Payable $4.4M
Deferred Revenue -
Current Debt -
Short Term Debt $812K
Total Non Current Liabilities $2.4M
Capital Lease Obligations $2.8M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $2.8M
Other Current Liabilities $22M
Other Non Current Liabilities -
Total Shareholder Equity $57M
Treasury Stock -
Retained Earnings -$574M
Common Stock $35K
Common Stock Shares Outstanding $140M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$84M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $425K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $114M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$106M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $455K
Total Revenue $455K
Cost Of Revenue $425K
Costof Goods And Services Sold $425K
Operating Income -$104M
Selling General And Administrative $56M
Research And Development $49M
Operating Expenses $105M
Investment Income Net -
Net Interest Income $3.5M
Interest Income $3.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $426K
Income Before Tax -$106M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$106M
Comprehensive Income Net Of Tax -
Ebit -$104M
Ebitda -$104M
Net Income -$106M

APLT News

APLT Profile

Applied Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for unmet medical needs, particularly in cardiovascular diseases, galactosemia, and complications arising from diabetes. With its headquarters in New York, the company is committed to advancing its pipeline of novel compounds aimed at addressing significant health challenges, leveraging cutting-edge research and patient-centric approaches. As it continues to progress through clinical trials, Applied Therapeutics aims to position itself as a leader in transforming treatment paradigms and improving patient outcomes in its target indications.

ATCH
+87.36%
$1.62
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
INTC
+25.22%
$31.18
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
DVLT
+31.33%
$0.45
NFE
+8.00%
$2.16
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
LYFT
+13.12%
$22.84
SOUN
+2.92%
$15.12
NUAI
-4.00%
$0.45
NEHC
-4.00%
$0.45
MARA
-1.08%
$17.34
RGTI
+9.94%
$21.99
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
F
+0.43%
$11.66
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
PGRE
-11.63%
$6.53
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
JOBY
-1.59%
$14.16
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
RR
+2.84%
$3.98
WBD
-1.42%
$17.98
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
AMD
-0.81%
$159.16
QS
+1.08%
$10.26
MULN
-6.96%
$0.06
WULF
+3.74%
$11.35
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
ETHD
-1.52%
$3.22
TLRY
-2.45%
$1.19
NOK
+1.95%
$4.70
QUBT
+4.97%
$17.71
VALE
-0.27%
$10.88
SRM
+53.27%
$10.30
IREN
+3.97%
$37.90
CIFR
+7.55%
$12.38
RZLV
-3.26%
$7.11
RIG
-2.01%
$3.40
CWD
+20.62%
$7.66
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
JD
+1.52%
$35.24
PLUG
+0.03%
$2.00
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
BTE
-2.29%
$2.54
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
MRVL
+3.07%
$70.98
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
RXRX
-2.68%
$4.71
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+1.52%
$17.54
ORCL
-1.70%
$301.41
JBLU
0.00%
$5.07
ROIV
+7.75%
$15.28
ETWO
0.00%
$3.30
T
+0.71%
$29.54
PEB
+2.07%
$11.80
WMT
+0.82%
$104.27
HPE
+1.22%
$24.73
PR
+1.26%
$13.56
NBIS
+5.19%
$94.08
APLD
+1.90%
$19.82
CRWV
+1.77%
$120.86
PDD
+4.49%
$134.86
NVDA
+2.74%
$174.96
KDP
+1.11%
$27.26
AFMD
-34.94%
$0.18
YAAS
-4.19%
$0.06
ATCH
+87.36%
$1.62
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
INTC
+25.22%
$31.18
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
DVLT
+31.33%
$0.45
NFE
+8.00%
$2.16
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
LYFT
+13.12%
$22.84
SOUN
+2.92%
$15.12
NUAI
-4.00%
$0.45
NEHC
-4.00%
$0.45
MARA
-1.08%
$17.34
RGTI
+9.94%
$21.99
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
F
+0.43%
$11.66
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
PGRE
-11.63%
$6.53
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
JOBY
-1.59%
$14.16
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
RR
+2.84%
$3.98
WBD
-1.42%
$17.98
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
AMD
-0.81%
$159.16
QS
+1.08%
$10.26
MULN
-6.96%
$0.06
WULF
+3.74%
$11.35
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
ETHD
-1.52%
$3.22
TLRY
-2.45%
$1.19
NOK
+1.95%
$4.70
QUBT
+4.97%
$17.71
VALE
-0.27%
$10.88
SRM
+53.27%
$10.30
IREN
+3.97%
$37.90
CIFR
+7.55%
$12.38
RZLV
-3.26%
$7.11
RIG
-2.01%
$3.40
CWD
+20.62%
$7.66
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
JD
+1.52%
$35.24
PLUG
+0.03%
$2.00
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
BTE
-2.29%
$2.54
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
MRVL
+3.07%
$70.98
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
RXRX
-2.68%
$4.71
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+1.52%
$17.54
ORCL
-1.70%
$301.41
JBLU
0.00%
$5.07
ROIV
+7.75%
$15.28
ETWO
0.00%
$3.30
T
+0.71%
$29.54
PEB
+2.07%
$11.80
WMT
+0.82%
$104.27
HPE
+1.22%
$24.73
PR
+1.26%
$13.56
NBIS
+5.19%
$94.08
APLD
+1.90%
$19.82
CRWV
+1.77%
$120.86
PDD
+4.49%
$134.86
NVDA
+2.74%
$174.96
KDP
+1.11%
$27.26
AFMD
-34.94%
$0.18
YAAS
-4.19%
$0.06
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.